Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02659540
Title A Pilot Study to Evaluate the Safety and Efficacy of Combination Checkpoint Blockade Plus External Beam Radiotherapy in Subjects With Stage IV Melanoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Ludwig Institute for Cancer Research



Ipilimumab + Nivolumab

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Stanford Cancer Institute Stanford California 94304 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
*Shaded cells indicate that there was no data available from for the field